Karen J. LaRochelle has broad biopharmaceutical strategy and collaborations experience. She spent 20 years with Bristol-Myers Squibb serving as Global Head of Negotiations and Head of Business Development in China, following earlier positions in alliance management, strategy, analysis and finance. Karen also lead a successful consultancy providing business development expertise to leading biotechnology companies including Exelixis and Chase Pharmaceuticals. Karen has negotiated and executed transactions with biotechnology, pharmaceutical, technology and international companies, several in excess of $1 billion, across therapeutic areas including oncology, neuroscience, virology and cardiovascular. Karen received her MBA from Columbia University and a BS in Industrial Engineering from Lehigh University. She leads the Business Development Advisory Board of New Jersey’s Biotechnology Council (BioNJ), and currently serves on the Lehigh University Engineering Advisory Board. Karen J. LaRochelle has broad biopharmaceutical strategy and collaborations experience. She spent 20 years with Bristol-Myers Squibb serving as Global Head of Negotiations and Head of Business Development in China, following earlier positions in alliance management, strategy, analysis and finance. Karen also lead a successful consultancy providing business development expertise to leading biotechnology companies including Exelixis and Chase Pharmaceuticals. Karen has negotiated and executed transactions with biotechnology, pharmaceutical, technology and international companies, several in excess of $1 billion, across therapeutic areas including oncology, neuroscience, virology and cardiovascular. Karen received her MBA from Columbia University and a BS in Industrial Engineering from Lehigh University. She leads the Business Development Advisory Board of New Jersey’s Biotechnology Council (BioNJ), and currently serves on the Lehigh University Engineering Advisory Board.

fermentation